DUX4 and neoplasm: This contrast between WT CIC acting as a tumor suppressor and CIC::DUX4 being an oncogene provides a rare opportunity to take knowledge learned from the natural evolution of CIC inactivation in WT CIC cancers and apply those strategies to potentially disable the CIC::DUX4 fusion oncoprotein.